海藻衍生的天然成分在肥胖中的作用:系统性审查
Jiao Tan1, K K Asanka Sanjeewa2, Ginnae Ahn3
1State Key Laboratory of Marine Food Processing & Safety Control, College of Food Science and Engineering, Ocean University of China, Qingdao, Shandong 266404, China.
Drug discovery today
|December 7, 2025
概括
海藻化合物显示出治疗肥胖和相关健康问题的前景. 这篇评论探讨了海藻.
科学领域:
- 海洋生物学 海洋生物学
- 营养保健品 营养保健品
- 药理学 药理学是指药理学的学科.
背景情况:
- 肥胖是一个全球性流行病,由不良饮食和不活动驱动.
- 它会导致严重的健康问题,如高血压,糖尿病和脂肪肝疾病.
- 有效的肥胖治疗是健康研究的主要重点.
研究的目的:
- 为了审查肥胖模型.
- 总结海藻衍生生物活性成分在治疗肥胖和相关疾病方面的潜力.
主要方法:
- 关于肥胖和海藻生物活性的科学研究的文献综述.
- 对海藻二次代谢物及其抗肥胖作用的研究分析.
主要成果:
- 海藻生物活性二次代谢物具有显著的抗肥胖潜力.
- 这些化合物可能为与肥胖相关的疾病提供治疗效益.
结论:
- 海藻衍生生物活性成分是抗肥胖药物开发的有希望的候选者.
- 对海藻生物活性的进一步研究可能会导致新的肥胖治疗方法.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
161
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
161
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
225
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
225
Drug Dosing: Obese Patients
202
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
202
Regulation of Food Intake
2.2K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.2K
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296


